News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Zylera Pharmaceuticals Announces Availability Of RELAMINE For The Treatment Of Osteoarthritis


1/25/2007 12:42:03 PM

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Zylera Pharmaceuticals announced today that new RELAMINE™ (chondroitin 300mg, glucosamine 400mg and primorine™ 425mg), a novel, prescription treatment for osteoarthritis, is now available for patients throughout the U.S. RELAMINE is the first and only prescription product that contains pharmaceutical quality glucosamine, chondroitin and primorine. RELAMINE helps to reduce joint swelling and control pain while slowing the onset and progression of osteoarthritis.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES